13 matokeo
CROSS REFERENCES TO RELATED APPLICATIONS
This application incorporates herein by reference in its entirety Chinese Patent Application No. CN201310663899.0 filed on Dec. 11, 2013 in the name of Zhifang Li, Hui Li, and Wei R. Chen, published Jul. 16, 2014.
FIELD OF THE INVENTION
The present invention
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to laser-based methods and systems for enhancing optical breakdown.
2. Background Art
Much effort has been devoted to research on laser-induced optical breakdown (LIOB) since the advent of powerful lasers, because of the
FIELD OF THE INVENTION
This invention is related to the field of biomedical applications of nanotechnology. More particularly, the invention is related to a new compound of immunologically modified carbon nanotubes and the use of the compound for delivering immunoadjuvants to tumor cells and for
FIELD OF THE INVENTION
This invention is related to the field of biomedical applications of nanotechnology. More particularly, the invention is related to a new compound of immunologically modified carbon nanotubes and the use of the compound for delivering immunoadjuvants to tumor cells and for
FIELD OF THE INVENTION
The present invention relates generally to the in vivo detection and measurement of the dose critical levels of certain anti-cancer drugs in blood, serum and other biological fluids, more specifically to the detection of such drugs using a probe DNA and still more specifically
This invention relates to lights and lighting, in particular to devices and methods for applying various wavelengths of light as a non-carcinogenic visible light source
BACKGROUND AND PRIOR ART
Numerous experiments document that hormonal changes are carcinogenic and the Federal government has
FIELD OF THE INVENTION
The present invention relates to the field of mammalian cellular physiology and, more particularly, to fluorescent molecules that are transported into a cell via the polyamine transport system.
BACKGROUND OF THE INVENTION
Polyamines are organic compounds having at least two
FIELD OF INVENTION
X-Ray Beam Therapy, Class 378, 424, 530
FEDERALLY SPONSORED RESEARCH
None;
SEQUENCE LISTING
Table of Contents attached
1. BACKGROUND OF THE INVENTION
Two hundred to five hundred Gy high dose and dose rate radiation therapy with Synchrotron generated microbeam is curative even for
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a fine-particulate, water-insoluble medicine, and a complex of the same with a polymer electrolyte. More particularly, the present invention is related to a medicine in the form of ultrafine particles obtained by
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to and the benefit under 35 U.S.C. .sctn. 119(a) of Korean Patent Application No. 10-2014-0046482, filed on Apr. 18, 2014 in the Korean Intellectual Property Office, the disclosure of which is incorporated herein by reference in
FIELD OF INVENTION
The disclosure herein relates to a drug delivery system.
BACKGROUND
Previously, the American Cancer Society estimated that 1,479,350 new cancer cases would be diagnosed in the United States during 2009 of which 219,440 would be lung and bronchus related. Although only the second
FIELD
The present disclosure relates to nanoparticles configured to traffic agents that inhibit hexokinase, such as 3-bromopyruvate, to different compartments of mitochondria such as the outer mitochondrial membrane, the inner mitochondrial membrane, the inter membrane space and methods of use
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the national stage of International Application No. PCT/BE2008/000099, filed Nov. 26, 2008, which claims benefit of UK Patent Application No. GB0723124.4, filed Nov. 26, 2007.
FIELD OF THE INVENTION
The present invention concerns a